Metraipolis › archive › dc_4e2947ae559f

Lifitegrast Degradation: Products and Pathways — Europe PMC PMID:41155936

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41155936
DOI
10.3390/pharmaceutics17101299
License (as archived)
solo-consultazione
Archived
2026-11-09T13:57:51.863Z
SHA-256 of the archived text
3c73c2200bc3f081d30b2e2653f9b2b99508d01372cb634bd940e2aafa700d5a
Stable URL of this page
https://metraipolis.com/documento/dc_4e2947ae559f

How to cite

Lifitegrast Degradation: Products and Pathways — Europe PMC PMID:41155936 — Europe PMC (en), https://europepmc.org/article/MED/41155936 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e2947ae559f (Metraipolis archive dc_4e2947ae559f, sha256 3c73c2200bc3f081d30b2e2653f9b2b99508d01372cb634bd940e2aafa700d5a)
BibTeX
@misc{dc4e2947ae559f,
  title = {Lifitegrast Degradation: Products and Pathways — Europe PMC PMID:41155936},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41155936},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e2947ae559f; sha256 3c73c2200bc3f081d30b2e2653f9b2b99508d01372cb634bd940e2aafa700d5a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155936. Agents can read the archived copy with the MCP tool read_document.